Skip Navigation
Skip to contents



12 results

Early Stage Lymphedema in Breast Cancer Patient Detected by Indocyanine Green Lymphography but not by Lymphoscintigraphy: A Case Report

Yoon JA, Shin MJ, Choi YJ, Kim JH, Kang T, Park H

  • J Breast Dis.
  • 2019 Dec;7(2):117-120.
  • doi: 10.14449/jbd.2019.7.2.117
Secondary upper extremity lymphedema after lymph node dissection in breast cancer patients is a major complication affecting their quality of life. As lymphatic function is compromised before symptoms develop in...
Recurrent Ipsilateral Breast Sparganosis: A Case Report

Ahn JH, Yi JY, Kim SJ, Hur MH

  • J Breast Dis.
  • 2019 Dec;7(2):113-116.
  • doi: 10.14449/jbd.2019.7.2.113
Sparganosis is a rare parasitic infection that can infect the abdominal wall, extremities, urogenital system, and/or central nervous system. Because the incidence of sparganosis is less than 2% of all...
Effect of Vitamin D on Bone Mineral Density Changes in Patients with Breast Cancer Receiving Adjuvant Aromatase Inhibitor Therapy

Park SH, Kim EY, Park CH

  • J Breast Dis.
  • 2019 Dec;7(2):105-112.
  • doi: 10.14449/jbd.2019.7.2.105
PURPOSE: We assessed bone mineral density (BMD) changes with aromatase inhibitor (AI) treatment in women with breast cancer and determined whether BMD T-scores changed with vitamin D supplementation. METHODS: This single-center,...
Incidence of Febrile Neutropenia in Advanced Breast Cancer Patients Receiving Adjuvant Docetaxel-Doxorubicin-Cyclophosphamide Chemotherapy in Korea and Its Impact on Prognosis

Park BK, Gwak H, Lim ST, Suh YJ, Jeon YW

  • J Breast Dis.
  • 2019 Dec;7(2):97-104.
  • doi: 10.14449/jbd.2019.7.2.97
PURPOSE: The concurrent regimen of docetaxel, doxorubicin, and cyclophosphamide (TAC) has been categorized as a high-risk factor for febrile neutropenia (FN). The incidence of FN was reported to be as...
Immediate Breast Reconstruction vs. Mastectomy Alone in Locally Advanced Breast Cancer; Local Recurrence and Distant Recurrence

Kim Y, Lee ES, Cheun JH, Jung J, Lee HB, Moon HG, Noh DY, Han W

  • J Breast Dis.
  • 2019 Dec;7(2):89-96.
  • doi: 10.14449/jbd.2019.7.2.89
PURPOSE: The oncologic safety of immediate breast reconstruction (IBR) has been demonstrated. However, the outcome of IBR for locally advanced breast cancer (LABC) is still under debate. We compared the...
Comparison of the Beneficial Effects of Adjuvant Chemotherapy among Young and Old Aged Breast Cancer Patients

Mok S, Yoo TK, Chae BJ

  • J Breast Dis.
  • 2019 Dec;7(2):81-88.
  • doi: 10.14449/jbd.2019.7.2.81
PURPOSE: Breast cancer rates are expected to rise with an increasingly aging society. However, research on breast cancer among elderly women is scarce. In the present study, we aimed to...
Long-term Follow-up of Pure Ductal Carcinoma in situ after Breast-Conserving Surgery

Yun KW, Kim J, Lee JW, Lee SB, Kim HJ, Chung IY, Ko BS, Son BH, Ahn SH

  • J Breast Dis.
  • 2019 Dec;7(2):73-80.
  • doi: 10.14449/jbd.2019.7.2.73
PURPOSE: Ductal carcinoma in situ (DCIS) is a high-risk disease for the development of invasive tumors. Although it is associated with excellent prognosis, many patients undergo extensive treatment with surgery,...
Predictive Value of the Standardized Uptake Value of 18F-fluorodeoxyglucose Positron Emission Tomography-Computed Tomography in Assessing Axillary Lymph Node Metastasis in Different Subtypes of Breast Cancer

Kim N, Choi J, Ko EB, Kim SH, Jun J, Kim HA, Noh WC, Seong MK

  • J Breast Dis.
  • 2019 Dec;7(2):65-72.
  • doi: 10.14449/jbd.2019.7.2.65
PURPOSE: This study aimed to examine the association between the maximum standardized uptake value (SUVmax) of different molecular subtypes of primary breast cancer with axillary lymph node (ALN) metastasis. METHODS: The...
Efficacy of Mastocheck for Screening of Early Breast Cancer: Comparison with Screening Mammography

Kim Y, Moon HG, Lee HB, Moon WK, Cho N, Chang JM, Han W, Noh DY

  • J Breast Dis.
  • 2019 Dec;7(2):59-64.
  • doi: 10.14449/jbd.2019.7.2.59
PURPOSE: This study was designed to verify the effectiveness of Mastocheck, a new diagnostic tool developed with proteomics techniques using plasma proteins. In addition, checked the current state of mammography...
Clinicopathological Significance of SMAD4 Expression in Breast Cancer

Woo JS, Chung MS, Paik SS

  • J Breast Dis.
  • 2019 Dec;7(2):52-58.
  • doi: 10.14449/jbd.2019.7.2.52
PURPOSE: SMAD4 is a member of the SMAD family and acts as a central mediator of transforming growth factor beta signaling. Little is known about SMAD4 expression and its prognostic...
Urinary Metabolites as Biomarkers for Diagnosis of Breast Cancer: A Preliminary Study

Park J, Shin Y, Kim TH, Kim DH, Lee A

  • J Breast Dis.
  • 2019 Dec;7(2):44-51.
  • doi: 10.14449/jbd.2019.7.2.44
PURPOSE: For early detection of breast cancer, tests with high sensitivity and specificity are needed. Metabolomics, the study of chemical processes involving metabolites, can be used to identify diagnostic biomarkers...
The effect of Tamoxifen on Patients with Gynecomastia

Oh JM, Won TW

  • J Breast Dis.
  • 2019 Dec;7(2):39-43.
  • doi: 10.14449/jbd.2019.7.2.39
PURPOSE: Gynecomastia is the most common cause of male breast enlargement and is a disease which can occur in men of all ages. The purpose of this study was to...

Go to Top

Copyright © 2020 by Korean Association of Medical Journal Editors. All rights reserved.     E-mail: